Cargando…
Assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery
PURPOSE: To study ocular surface signs, symptoms, and tear film composition following prophylactic thermal pulsation therapy (TPT) prior to refractive surgery, and to compare these outcomes with those who underwent TPT after refractive surgery. METHODS: Patients with mild-to-moderate evaporative dry...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276699/ https://www.ncbi.nlm.nih.gov/pubmed/37026292 http://dx.doi.org/10.4103/IJO.IJO_3361_22 |
_version_ | 1785060132121477120 |
---|---|
author | Shetty, Rohit Khamar, Pooja Nair, Archana Padmanabhan Pandian, Packiya Raj Vaidya, Tanuja Arun Trivedi, Divya Sethu, Swaminathan Roy, Subhasita Mahajan, Sanjay Shirodkar, Sailie |
author_facet | Shetty, Rohit Khamar, Pooja Nair, Archana Padmanabhan Pandian, Packiya Raj Vaidya, Tanuja Arun Trivedi, Divya Sethu, Swaminathan Roy, Subhasita Mahajan, Sanjay Shirodkar, Sailie |
author_sort | Shetty, Rohit |
collection | PubMed |
description | PURPOSE: To study ocular surface signs, symptoms, and tear film composition following prophylactic thermal pulsation therapy (TPT) prior to refractive surgery, and to compare these outcomes with those who underwent TPT after refractive surgery. METHODS: Patients with mild-to-moderate evaporative dry eye disease (DED) and/or meibomian gland dysfunction (MGD) undergoing refractive surgery were included. Group 1 patients received TPT (LipiFlow) prior to laser-assisted in situ keratomileusis (LASIK; n = 32, 64 eyes), and Group 2 patients received TPT three months after LASIK (n = 27, 52 eyes). Ocular Surface Disease Index (OSDI) score, Schirmer’s test (ST1, ST2), Tear Breakup Time (TBUT), meibography, and tear fluid were obtained preoperatively and at three months postoperatively in Groups 1 and 2. Additional postoperative evaluation was performed three months after TPT in Group 2. Tear soluble factor profile was measured by multiplex enzyme-linked immunosorbent assay (ELISA) using flow cytometry. RESULTS: Postoperative OSDI score was significantly lower and TBUT was significantly higher when compared with matched preoperative values of Group 1 participants. On the other hand, the postoperative OSDI score was significantly higher and TBUT significantly lower when compared with matched preoperative values of Group 2 participants. TPT significantly reduced the postoperative elevation in OSDI and significantly reduced the postoperative reduction in TBUT in Group 2 participants. Tear Matrix metalloproteinase-9/ Tissue inhibitor matrix metalloproteinase 1 (MMP-9/TIMP1) ratio was significantly higher, postoperatively, when compared with matched preoperative levels in Group 2. However, MMP9/TIMP1 ratio remained unaltered in Group 1 participants. CONCLUSION: TPT prior to refractive surgery improved postsurgical ocular surface signs and symptoms and reduced tear inflammatory factors, thereby suggesting the plausibility of reduced post-refractive surgery DED in patients. |
format | Online Article Text |
id | pubmed-10276699 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-102766992023-06-18 Assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery Shetty, Rohit Khamar, Pooja Nair, Archana Padmanabhan Pandian, Packiya Raj Vaidya, Tanuja Arun Trivedi, Divya Sethu, Swaminathan Roy, Subhasita Mahajan, Sanjay Shirodkar, Sailie Indian J Ophthalmol Original Article PURPOSE: To study ocular surface signs, symptoms, and tear film composition following prophylactic thermal pulsation therapy (TPT) prior to refractive surgery, and to compare these outcomes with those who underwent TPT after refractive surgery. METHODS: Patients with mild-to-moderate evaporative dry eye disease (DED) and/or meibomian gland dysfunction (MGD) undergoing refractive surgery were included. Group 1 patients received TPT (LipiFlow) prior to laser-assisted in situ keratomileusis (LASIK; n = 32, 64 eyes), and Group 2 patients received TPT three months after LASIK (n = 27, 52 eyes). Ocular Surface Disease Index (OSDI) score, Schirmer’s test (ST1, ST2), Tear Breakup Time (TBUT), meibography, and tear fluid were obtained preoperatively and at three months postoperatively in Groups 1 and 2. Additional postoperative evaluation was performed three months after TPT in Group 2. Tear soluble factor profile was measured by multiplex enzyme-linked immunosorbent assay (ELISA) using flow cytometry. RESULTS: Postoperative OSDI score was significantly lower and TBUT was significantly higher when compared with matched preoperative values of Group 1 participants. On the other hand, the postoperative OSDI score was significantly higher and TBUT significantly lower when compared with matched preoperative values of Group 2 participants. TPT significantly reduced the postoperative elevation in OSDI and significantly reduced the postoperative reduction in TBUT in Group 2 participants. Tear Matrix metalloproteinase-9/ Tissue inhibitor matrix metalloproteinase 1 (MMP-9/TIMP1) ratio was significantly higher, postoperatively, when compared with matched preoperative levels in Group 2. However, MMP9/TIMP1 ratio remained unaltered in Group 1 participants. CONCLUSION: TPT prior to refractive surgery improved postsurgical ocular surface signs and symptoms and reduced tear inflammatory factors, thereby suggesting the plausibility of reduced post-refractive surgery DED in patients. Wolters Kluwer - Medknow 2023-04 2023-04-05 /pmc/articles/PMC10276699/ /pubmed/37026292 http://dx.doi.org/10.4103/IJO.IJO_3361_22 Text en Copyright: © 2023 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Shetty, Rohit Khamar, Pooja Nair, Archana Padmanabhan Pandian, Packiya Raj Vaidya, Tanuja Arun Trivedi, Divya Sethu, Swaminathan Roy, Subhasita Mahajan, Sanjay Shirodkar, Sailie Assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery |
title | Assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery |
title_full | Assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery |
title_fullStr | Assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery |
title_full_unstemmed | Assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery |
title_short | Assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery |
title_sort | assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276699/ https://www.ncbi.nlm.nih.gov/pubmed/37026292 http://dx.doi.org/10.4103/IJO.IJO_3361_22 |
work_keys_str_mv | AT shettyrohit assessingclinicalandmolecularoutcomesofprophylacticthermalpulsationtherapyonocularsurfacehealthfollowingrefractivesurgery AT khamarpooja assessingclinicalandmolecularoutcomesofprophylacticthermalpulsationtherapyonocularsurfacehealthfollowingrefractivesurgery AT nairarchanapadmanabhan assessingclinicalandmolecularoutcomesofprophylacticthermalpulsationtherapyonocularsurfacehealthfollowingrefractivesurgery AT pandianpackiyaraj assessingclinicalandmolecularoutcomesofprophylacticthermalpulsationtherapyonocularsurfacehealthfollowingrefractivesurgery AT vaidyatanujaarun assessingclinicalandmolecularoutcomesofprophylacticthermalpulsationtherapyonocularsurfacehealthfollowingrefractivesurgery AT trivedidivya assessingclinicalandmolecularoutcomesofprophylacticthermalpulsationtherapyonocularsurfacehealthfollowingrefractivesurgery AT sethuswaminathan assessingclinicalandmolecularoutcomesofprophylacticthermalpulsationtherapyonocularsurfacehealthfollowingrefractivesurgery AT roysubhasita assessingclinicalandmolecularoutcomesofprophylacticthermalpulsationtherapyonocularsurfacehealthfollowingrefractivesurgery AT mahajansanjay assessingclinicalandmolecularoutcomesofprophylacticthermalpulsationtherapyonocularsurfacehealthfollowingrefractivesurgery AT shirodkarsailie assessingclinicalandmolecularoutcomesofprophylacticthermalpulsationtherapyonocularsurfacehealthfollowingrefractivesurgery |